Researchers have developed experimental obesity drugs that target mitochondria – the “powerhouses” of the cell – to work harder and burn more calories, potentially paving the way for a new class of weight‑loss treatments. The approach focuses on making cells waste energy as heat instead of efficiently converting it into usable fuel.
The team, led by scientists at the University of Technology Sydney in Australia, is working on “mitochondrial uncouplers”, a family of molecules that make energy production in cells less efficient. By disrupting how mitochondria generate adenosine triphosphate (ATP), these compounds push cells to burn more fats to meet their energy needs, increasing overall energy expenditure.
“Mitochondria are often called the powerhouses of the cell. They turn the food you eat into chemical energy, called ATP or adenosine triphosphate,” said lead researcher Tristan Rawling, associate professor of medicinal chemistry at the University of Technology Sydney. “Mitochondrial uncouplers disrupt this process, triggering cells to consume more fats to meet their energy needs,” he explained, highlighting the potential of this mechanism to support future obesity therapies.
